Skip to main content

Brett Davis, Global Assets Leader | Deloitte

Global Assets Leader | Principal | Deloitte Consulting LP

Brett Davis is General Manager of Converge by Deloitte and Deloitte Consulting’s Global Assets Leader. As General Manager of Converge, Brett is responsible for managing Deloitte’s $750M+ investment in creating new businesses and platforms that help shape and transform industries ethically and responsibly. These next generation platforms support the transformation of and convergence points between the consumer, financial services and health care sectors.

As Deloitte Consulting’s Global Assets Leader, Brett has responsibilities across a global portfolio of high growth asset enabled consulting offerings that are powered by innovative new technologies. In this role, he leads the development of consulting’s portfolio asset strategy, investment prioritization, go-to-market and commercial enablement, as well as the establishment of new client engagement models and transfer of intellectual property across priority markets.

He was previously the founder and General Manager of ConvergeHEALTH, a business unit focused on supporting the information-based transformation of health care and life sciences that he co-founded and launched in 2014. In this role he was responsible for managing Deloitte’s $200M+ investment in new digital engagement and advanced analytics platforms to support the industry’s shift to value based, personalized health care. Today, ConvergeHEALTH platforms are live in 25 countries supporting millions of patients and leading biopharmaceutical and health care clients in their digital transformations.

He has been a keynote speaker at numerous industry conferences including HIMSS, AMIA, DIA, ASCO, the National Chamber of Commerce Health Summit, Personalized Medicine World Conference, Harvard Partners Personalized Medicine Conference, and the Annual National Quality Colloquium. Brett has published numerous white papers on the transformative impact of health information technology, and been quoted in publications such as the London Times, InformationWeek, Advanced Clinical Trials, Computer World, Health Data Management, and Bio-IT World.

Prior to joining Deloitte, Davis held leadership roles in life sciences and health care at Oracle and IBM.